Skip to content

Docs (opens in a new tab)Pricing Research Benchmark

Sign in Sign up

I

IKT

Inhibikase Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

NASDAQ · Healthcare · Biotechnology · US

$2.50

−0.79%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsAnalysis

Analysis

No published Drillr research on IKT yet.

Ask Drillr about IKT Browse research →

The idea engine
for fundamental investors.

Product

Ask drillr Watchlist

Resources

Research Methodology Benchmark Docs (opens in a new tab)

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Pricing Privacy Terms© 2026 LIL GREBE INC.